All results
2 results for impact
-
PK sensitivity in fluticasone propionate dry powder inhalers
When a drug company first develops a drug, the company has to show the Food and Drug Administration (FDA) that the drug is safe and effective. If FDA concludes…
- Ages
- 18 Years - 50 Years
- Sexes
- All
-
Sensitivity of Pharmacokinetics to Particle Size Distribution of Suspension-based Nasal Sprays
Currently FDA does not accept pharmacokinetic studies to show bioequivalence of locally-acting nasal suspension formulations. However, bioequivalence is…
- Ages
- 18 Years - 50 Years
- Sexes
- All